153 related articles for article (PubMed ID: 30335245)
1. Drug utilization study of two generic antibiotics in a tertiary hospital in Bogotá.
López JJ; Cortázar Y; Acosta Á; Vargas-Peláez CM; Rossi F
Biomedica; 2018 Sep; 38(3):398-406. PubMed ID: 30335245
[TBL] [Abstract][Full Text] [Related]
2. Clinical and economic impact of generic versus brand name meropenem use in an intensive care unit in Colombia.
Ordóñez K; Feinstein MM; Reyes S; Hernández-Gómez C; Pallares C; Villegas MV
Braz J Infect Dis; 2019; 23(4):237-245. PubMed ID: 31344357
[TBL] [Abstract][Full Text] [Related]
3. [Surveillance of healthcare associated infections, bacterial resistance and antibiotic consumption in high-complexity hospitals in Colombia, 2011].
Villalobos AP; Barrero LI; Rivera SM; Ovalle MV; Valera D
Biomedica; 2014 Apr; 34 Suppl 1():67-80. PubMed ID: 24968038
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of effectiveness and safety of generic formulation of meropenem for treatment of infections at Siriraj Hospital.
Angkasekwinai N; Werarak P; Chaiyasoot K; Thamlikitkul V
J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S217-24. PubMed ID: 21721450
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic effectiveness of the generic preparation of meropenem (Mapenem) in the treatment of moderate to severe infection in children.
Punpanich W; Srisarang S; Prachantasen U
J Med Assoc Thai; 2012 Jul; 95(7):895-902. PubMed ID: 22919984
[TBL] [Abstract][Full Text] [Related]
6. Continuous epileptiform discharges in patients treated with cefepime or meropenem.
Naeije G; Lorent S; Vincent JL; Legros B
Arch Neurol; 2011 Oct; 68(10):1303-7. PubMed ID: 21987544
[TBL] [Abstract][Full Text] [Related]
7. [Mortality risk factors associated with healthcare infections in a tertiary level university hospital in Colombia].
Pallares CJ; Martínez E
Biomedica; 2014 Apr; 34 Suppl 1():148-55. PubMed ID: 24968046
[TBL] [Abstract][Full Text] [Related]
8. Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
Wagenlehner FM; Gasink LB; McGovern PC; Moeck G; McLeroth P; Dorr M; Dane A; Henkel T;
N Engl J Med; 2024 Feb; 390(7):611-622. PubMed ID: 38354140
[TBL] [Abstract][Full Text] [Related]
9. Antimicrobial prescription patterns in a tertiary-care pediatric unit in Thailand.
Chautrakarn S; Anugulruengkitt S; Puthanakit T; Rattananupong T; Hiransuthikul N
Pediatr Int; 2020 Jun; 62(6):683-687. PubMed ID: 31957141
[TBL] [Abstract][Full Text] [Related]
10. Cefozopran, meropenem, or imipenem-cilastatin compared with cefepime as empirical therapy in febrile neutropenic adult patients: A multicenter prospective randomized trial.
Nakane T; Tamura K; Hino M; Tamaki T; Yoshida I; Fukushima T; Tatsumi Y; Nakagawa Y; Hatanaka K; Takahashi T; Akiyama N; Tanimoto M; Ohyashiki K; Urabe A; Masaoka T; Kanamaru A;
J Infect Chemother; 2015 Jan; 21(1):16-22. PubMed ID: 25239059
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic effectiveness of a generic versus original meropenem in serious infections.
Tansuphasawadikul S; Simaroj S; Chantarothorn S; Nuntachit N; Jutivorakool K; Munsakul W; Yomtem K; Tangkosakul T; Wannasunthornchai S
J Med Assoc Thai; 2011 Feb; 94(2):172-8. PubMed ID: 21534363
[TBL] [Abstract][Full Text] [Related]
12. Incidence of Acute Kidney Injury among Patients Treated with Piperacillin-Tazobactam or Meropenem in Combination with Vancomycin.
Rutter WC; Burgess DS
Antimicrob Agents Chemother; 2018 Jul; 62(7):. PubMed ID: 29712661
[TBL] [Abstract][Full Text] [Related]
13. Impact of penicillin allergy records on carbapenem prescribing: an observational retrospective cohort study.
Powell N; West R; Sandoe J
J Hosp Infect; 2019 Apr; 101(4):467-470. PubMed ID: 30529507
[TBL] [Abstract][Full Text] [Related]
14. Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010.
Levy ER; Swami S; Dubois SG; Wendt R; Banerjee R
Infect Control Hosp Epidemiol; 2012 Apr; 33(4):346-53. PubMed ID: 22418629
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the prevalence of convulsions associated with the use of cefepime and meropenem.
Tanaka A; Takechi K; Watanabe S; Tanaka M; Suemaru K; Araki H
Int J Clin Pharm; 2013 Oct; 35(5):683-7. PubMed ID: 23733559
[TBL] [Abstract][Full Text] [Related]
16. Drug utilization evaluation of meropenem and correlation of side effects with renal status of patients in a teaching based hospital.
Khan MU; Yousuf RI; Shoaib MH
Pak J Pharm Sci; 2014 Sep; 27(5 Spec no):1503-8. PubMed ID: 25176244
[TBL] [Abstract][Full Text] [Related]
17. Experience with cefepime versus meropenem as empiric monotherapy for neutropenia and fever in pediatric patients with solid tumors.
Oguz A; Karadeniz C; Citak EC; Cil V; Eldes N
Pediatr Hematol Oncol; 2006; 23(3):245-53. PubMed ID: 16517540
[TBL] [Abstract][Full Text] [Related]
18. Antibiotic prescribing in medical intensive care units--a comparison between two private sector hospitals in Central India.
Sharma M; Damlin AL; Sharma A; Stålsby Lundborg C
Infect Dis (Lond); 2015 May; 47(5):302-9. PubMed ID: 25708090
[TBL] [Abstract][Full Text] [Related]
19. Cefepime-Taniborbactam in Complicated Urinary Tract Infection.
Manesh A; Varghese GM; Paterson DL
N Engl J Med; 2024 May; 390(20):1938. PubMed ID: 38810201
[No Abstract] [Full Text] [Related]
20. The safety of cefepime and ceftazidime in pediatric oncology patients.
Hoffman JM; Frediani J; Herr M; Flynn PM; Adderson EE
Pediatr Blood Cancer; 2013 May; 60(5):806-9. PubMed ID: 23382054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
